Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

NCT00449072 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

OTHER: Placebo
OTHER: Placebo
DRUG: TAA-AQ, Nasacort® AQ
DRUG: Claritin®

Sponsor

Sanofi